Delivery Order SPE2DB20D3505-SPE2DB25FYCFX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,581.32 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply delivery under the company's existing contract vehicle with DLA. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,227.30 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with performance completed in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The award was issued on September 12, 2025, with an ultimate completion date of September 15, 2025, and carries no set-aside designation. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,660.27 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with an ultimate completion date of September 12, 2025. This competitive, firm fixed-price delivery order was issued under no set-aside designation. The prime contractor, AmerisourceBergen Drug Corp, is headquartered in Conshohocken, Pennsylvania, and serves as a major pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,890.69 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, represents a continuation of the company's pharmaceutical supply services to federal medical procurement needs. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,441.94 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count packages) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency has awarded a delivery order valued at $3,232.63 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units. This competitively awarded contract, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,640.38 to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units. This non-competitive, firm fixed-price delivery order is set to be completed by September 5, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency awarded a $3,473.86 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's broader federal pharmaceutical supply portfolio supporting...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,613.64 for 100 tablets of Ambien CR 6.25 mg on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen...
- The Defense Logistics Agency awarded a $4,118.84 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg on July 22, 2025, with ultimate completion scheduled for July 23, 2025. This contract utilizes firm fixed pricing and carries no set-aside designation, reflecting a competitively awarded transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FYCFXDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,876.64 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg. This competitively awarded, firm fixed-price delivery order was issued on September 8, 2025, with an ultimate completion date of September 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction typical of routine pharmaceutical replenishment orders within the federal medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp leverages this comprehensive global pharmaceutical support vehicle to supply medications and medical supplies across multiple therapeutic domains to support military healthcare systems, the Defense Health Agency, the U.S. Coast Guard, and other government healthcare entities. The company's consistent receipt of competitively awarded delivery orders demonstrates its established capability to meet federal procurement requirements for pharmaceutical products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 9/8/25 |